BIOHIT GROUP FINANCIAL STATEMENT RELEASE 2016
Biohit Oyj’s CEO Semi Korpela will return to work on 20.2.2017
Biohit Oyj CEO Semi Korpela takes sick leave
Tampere Doctor 2017
Biohit Oyj is a globally operating Finnish biotechnology company established in 1988. Biohit’s mission is “Innovating for Health”.
Biohit is headquartered in Helsinki and has subsidiaries in Italy and the UK. Biohit’s Series B share (BIOBV) is quoted on NASDAQ OMX Helsinki since 1999, Small cap/Healthcare.